Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

I Disagree! The Choice of Rotational Atherectomy, Orbital Atherectom…

Controversies in Interventional Cardiovascular Therapies - CICT 2024

E. Shlofmitz

Therapeutic Hypothermia After Cardiac Arrest

John McPherson

ESC 2024 Insights: Comparison of Different Calcium Modification Stra…

ESC 2024 Insights

K. Yasumura

Basics of OCT Imaging

FACET

N. Pinilla-Echeverri

OCT Use in Vessel Assessment: Calcium and Beyond

FACET

N. Pinilla-Echeverri

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

Ultra-Low Contrast PCI

ARCH Advanced Revascularization Symposium

J. Kerrigan